Skip to main content
NCBI home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1981 Mar;134(3):234–241.

Thrombosis: its role and prevention in cardiovascular events--Part I. Concepts of thrombogenesis and its prevention.

L A Harker
PMCID: PMC1272610  PMID: 7269560

Full text

PDF
234

Images in this article

236Figure 1.
on p.236

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ali M., McDonald J. W. Reversible and irreversible inhibition of platelet cyclooxygenase and serotonin release by nonsteroidal antinflammatory drugs. Thromb Res. 1978 Dec;13(6):1057–1065. doi: 10.1016/0049-3848(78)90234-7. [DOI] [PubMed] [Google Scholar]
  2. Baum R. S., Alvarez H., 3rd, Cobb L. A. Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation. 1974 Dec;50(6):1231–1235. doi: 10.1161/01.cir.50.6.1231. [DOI] [PubMed] [Google Scholar]
  3. Bell R. L., Kennerly D. A., Stanford N., Majerus P. W. Diglyceride lipase: a pathway for arachidonate release from human platelets. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3238–3241. doi: 10.1073/pnas.76.7.3238. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bills T. K., Smith J. B., Silver M. J. Selective release of archidonic acid from the phospholipids of human platelets in response to thrombin. J Clin Invest. 1977 Jul;60(1):1–6. doi: 10.1172/JCI108745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blackwell G. J. Phospholipase A2 and platelet aggregation. Adv Prostaglandin Thromboxane Res. 1978;3:137–142. [PubMed] [Google Scholar]
  6. Blumberg A. L., Denny S. E., Marshall G. R., Needleman P. Blood vessel-hormone interactions: angiotensin, bradykinin, and prostaglandins. Am J Physiol. 1977 Mar;232(3):H305–H310. doi: 10.1152/ajpheart.1977.232.3.H305. [DOI] [PubMed] [Google Scholar]
  7. Bolton A. E., Ludlam C. A., Pepper D. S., Moore S., Cash J. D. A radioimmunoassay for platelet factor 4. Thromb Res. 1976 Jan;8(1):51–58. doi: 10.1016/0049-3848(76)90122-5. [DOI] [PubMed] [Google Scholar]
  8. Chandler A. B., Chapman I., Erhardt L. R., Roberts W. C., Schwartz C. J., Sinapius D., Spain D. M., Sherry S., Ness P. M., Simon T. L. Coronary thrombosis in myocardial infarction. Report of a workshop on the role of coronary thrombosis in the pathogenesis of acute myocardial infarction. Am J Cardiol. 1974 Dec;34(7):823–833. doi: 10.1016/0002-9149(74)90703-6. [DOI] [PubMed] [Google Scholar]
  9. Charo I. F., Feinman R. D., Detwiler T. C. Interrelations of platelet aggregation and secretion. J Clin Invest. 1977 Oct;60(4):866–873. doi: 10.1172/JCI108841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Clowes A. W., Karnovsky M. J. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat. Lab Invest. 1977 Apr;36(4):452–464. [PubMed] [Google Scholar]
  11. Colman R. W. Platelet function in hyperbetalipoproteinemia. Thromb Haemost. 1978 Apr 30;39(2):284–293. [PubMed] [Google Scholar]
  12. Doyle D. J., Chesterman C. N., Cade J. F., McGready J. R., Rennie G. C., Morgan F. J. Plasma concentrations of platelet-specific proteins correlated with platelet survival. Blood. 1980 Jan;55(1):82–84. [PubMed] [Google Scholar]
  13. Eldor A., Weksler B. B. Heparin and dextran sulfate antagonize PGI2 inhibition of platelet aggregation. Thromb Res. 1979;16(5-6):617–628. doi: 10.1016/0049-3848(79)90206-8. [DOI] [PubMed] [Google Scholar]
  14. Favis G. R., Colman R. W. The action of halofenate on platelet shape change and prostaglandin synthesis. J Lab Clin Med. 1978 Jul;92(1):45–52. [PubMed] [Google Scholar]
  15. Folts J. D., Crowell E. B., Jr, Rowe G. G. Platelet aggregation in partially obstructed vessels and its elimination with aspirin. Circulation. 1976 Sep;54(3):365–370. doi: 10.1161/01.cir.54.3.365. [DOI] [PubMed] [Google Scholar]
  16. Friedman R. J., Stemerman M. B., Wenz B., Moore S., Gauldie J., Gent M., Tiell M. L., Spaet H. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization. J Clin Invest. 1977 Nov;60(5):1191–1201. doi: 10.1172/JCI108872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Frishman W. H., Christodoulou J., Weksler B., Smithen C., Killip T., Scheidt S. Abrupt propranolol withdrawal in angina pectoris: effects on platelet aggregation and exercise tolerance. Am Heart J. 1978 Feb;95(2):169–179. doi: 10.1016/0002-8703(78)90460-x. [DOI] [PubMed] [Google Scholar]
  18. Goodwin D. A., Bushberg J. T., Doherty P. W., Lipton M. J., Conley F. K., Diamanti C. I., Meares C. F. Indium-111-labeled autologous platelets for location of vascular thrombi in humans. J Nucl Med. 1978 Jun;19(6):626–634. [PubMed] [Google Scholar]
  19. HOVIG T. RELEASE OF A PLATELET-AGGREGATING SUBSTANCE (ADENOSINE DIPHOSPHATE) FROM RABBIT BLOOD PLATELETS INDUCED BY SALINE "EXTRACT" OF TENDONS. Thromb Diath Haemorrh. 1963 Jul 15;143:264–278. [PubMed] [Google Scholar]
  20. Haerem J. W. Mural platelet microthrombi and major acute lesions of main epicardial arteries in sudden coronary death. Atherosclerosis. 1974 May-Jun;19(3):529–541. doi: 10.1016/s0021-9150(74)80017-1. [DOI] [PubMed] [Google Scholar]
  21. Haerem J. W. Myocardial lesions in sudden, unexpected coronary death. Am Heart J. 1975 Nov;90(5):562–568. doi: 10.1016/0002-8703(75)90218-5. [DOI] [PubMed] [Google Scholar]
  22. Haft J. I., Gershengorn K., Kranz P. D., Oestreicher R. Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation. Am J Cardiol. 1972 Dec;30(8):838–843. doi: 10.1016/0002-9149(72)90008-2. [DOI] [PubMed] [Google Scholar]
  23. Haft J. I., Kranz P. D., Albert F. J., Fani K. Intravascular platelet aggregation in the heart induced by norepinephrine. Microscopic studies. Circulation. 1972 Oct;46(4):698–708. doi: 10.1161/01.cir.46.4.698. [DOI] [PubMed] [Google Scholar]
  24. Hampton J. R., Gorlin R. Platelet studies in patients with coronary artery disease and in their relatives. Br Heart J. 1972 May;34(5):465–471. doi: 10.1136/hrt.34.5.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Harker L. A., Hanson S. R. Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention. J Clin Invest. 1979 Aug;64(2):559–560. doi: 10.1172/JCI109494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Harker L. A., Ross R., Slichter S. J., Scott C. R. Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976 Sep;58(3):731–741. doi: 10.1172/JCI108520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Harker L. A., Slichter S. J. Platelet and fibrinogen consumption in man. N Engl J Med. 1972 Nov 16;287(20):999–1005. doi: 10.1056/NEJM197211162872001. [DOI] [PubMed] [Google Scholar]
  28. Harker L. A., Slichter S. J., Scott C. R., Ross R. Homocystinemia. Vascular injury and arterial thrombosis. N Engl J Med. 1974 Sep 12;291(11):537–543. doi: 10.1056/NEJM197409122911101. [DOI] [PubMed] [Google Scholar]
  29. Haslam R. J., Davidson M. M., Davies T., Lynham J. A., McClenaghan M. D. Regulation of blood platelet function by cyclic nucleotides. Adv Cyclic Nucleotide Res. 1978;9:533–552. [PubMed] [Google Scholar]
  30. Jorgensen L., Rowsell H. C., Hovig T., Glynn M. F., Mustard J. F. Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Lab Invest. 1967 Dec;17(6):616–644. [PubMed] [Google Scholar]
  31. Kannel W. B., Doyle J. T., McNamara P. M., Quickenton P., Gordon T. Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation. 1975 Apr;51(4):606–613. doi: 10.1161/01.cir.51.4.606. [DOI] [PubMed] [Google Scholar]
  32. Kaplan K. L., Nossel H. L., Drillings M., Lesznik G. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation. Br J Haematol. 1978 May;39(1):129–146. doi: 10.1111/j.1365-2141.1978.tb07135.x. [DOI] [PubMed] [Google Scholar]
  33. Leibovich S. J., Ross R. A macrophage-dependent factor that stimulates the proliferation of fibroblasts in vitro. Am J Pathol. 1976 Sep;84(3):501–514. [PMC free article] [PubMed] [Google Scholar]
  34. Majno G., Joris I. Endothelium 1977: a review. Adv Exp Med Biol. 1978;104:169-225, 481-526. doi: 10.1007/978-1-4684-7787-0_9. [DOI] [PubMed] [Google Scholar]
  35. Maseri A., L'Abbate A., Baroldi G., Chierchia S., Marzilli M., Ballestra A. M., Severi S., Parodi O., Biagini A., Distante A. Coronary vasospasm as a possible cause of myocardial infarction. A conclusion derived from the study of "preinfarction" angina. N Engl J Med. 1978 Dec 7;299(23):1271–1277. doi: 10.1056/NEJM197812072992303. [DOI] [PubMed] [Google Scholar]
  36. Mehta J., Mehta P., Pepine C. J. Platelet aggregation in aortic and coronary venous blood in patients with and without coronary disease. 3. Role of tachycardia stress and propranolol. Circulation. 1978 Nov;58(5):881–886. doi: 10.1161/01.cir.58.5.881. [DOI] [PubMed] [Google Scholar]
  37. Minick C. R., Murphy G. E. Experimental induction of atheroarteriosclerosis by the synergy of allergic injury to arteries and lipid-rich diet. II. Effect of repeatedly injected foreign protein in rabbits fed a lipid-rich, cholesterol-poor diet. Am J Pathol. 1973 Nov;73(2):265–300. [PMC free article] [PubMed] [Google Scholar]
  38. Moncada S., Bunting S., Mullane K., Thorogood P., Vane J. R., Raz A., Needleman P. Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins. 1977 Apr;13(4):611–618. doi: 10.1016/0090-6980(77)90232-5. [DOI] [PubMed] [Google Scholar]
  39. Moncada S., Korbut R. Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin. Lancet. 1978 Jun 17;1(8077):1286–1289. doi: 10.1016/s0140-6736(78)91269-2. [DOI] [PubMed] [Google Scholar]
  40. Moncada S., Vane J. R. Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls. N Engl J Med. 1979 May 17;300(20):1142–1147. doi: 10.1056/NEJM197905173002006. [DOI] [PubMed] [Google Scholar]
  41. Moore S. Thromboatherosclerosis in normolipemic rabbits. A result of continued endothelial damage. Lab Invest. 1973 Nov;29(5):478–487. [PubMed] [Google Scholar]
  42. Moschos C. B., Haider B., De La Cruz C., Jr, Lyons M. M., Regan T. J. Antiarrhythmic effects of aspirin during nonthrombotic coronary occlusion. Circulation. 1978 Apr;57(4):681–684. doi: 10.1161/01.cir.57.4.681. [DOI] [PubMed] [Google Scholar]
  43. Mustard J. F., Packham M. A. Factors influencing platelet function: adhesion, release, and aggregation. Pharmacol Rev. 1970 Jun;22(2):97–187. [PubMed] [Google Scholar]
  44. Nemerson Y., Pitlick F. A. The tissue factor pathway of blood coagulation. Prog Hemost Thromb. 1972;1:1–37. [PubMed] [Google Scholar]
  45. Niewiarowski S., Regoeczi E., Stewart G. J., Senyl A. F., Mustard J. F. Platelet interaction with polymerizing fibrin. J Clin Invest. 1972 Mar;51(3):685–699. doi: 10.1172/JCI106857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Oliva P. B., Breckinridge J. C. Arteriographic evidence of coronary arterial spasm in acute myocardial infarction. Circulation. 1977 Sep;56(3):366–374. doi: 10.1161/01.cir.56.3.366. [DOI] [PubMed] [Google Scholar]
  47. Ritchie J. L., Cobb L. A., Harker L. A. Platelet survival in patients previously resuscitated from out-of-hospital ventricular fibrillation. J Lab Clin Med. 1979 Feb;93(2):310–315. [PubMed] [Google Scholar]
  48. Ritchie J. L., Harker L. A. Platelet and fibrinogen survival in coronary atherosclerosis. Response to medical and surgical therapy. Am J Cardiol. 1977 Apr;39(4):595–598. doi: 10.1016/s0002-9149(77)80171-9. [DOI] [PubMed] [Google Scholar]
  49. Roberts A. J., Jacobstein J. G., Cipriano P. R., Alonso D. R., Combes J. R., Gay W. A., Jr Effectiveness of dipyridamole in reducing the size of experimental myocardial infarction. Circulation. 1980 Feb;61(2):228–236. doi: 10.1161/01.cir.61.2.228. [DOI] [PubMed] [Google Scholar]
  50. Ross R., Harker L. Hyperlipidemia and atherosclerosis. Science. 1976 Sep 17;193(4258):1094–1100. doi: 10.1126/science.822515. [DOI] [PubMed] [Google Scholar]
  51. Salzman E. W., Rosenberg R. D., Smith M. H., Lindon J. N., Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest. 1980 Jan;65(1):64–73. doi: 10.1172/JCI109661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Schwartz C. J., Chandler A. B., Gerrity R. G., Naito H. K. Clinical and pathological aspects of arterial thrombosis and thromboembolism. Adv Exp Med Biol. 1978;104:111–126. doi: 10.1007/978-1-4684-7787-0_6. [DOI] [PubMed] [Google Scholar]
  53. Slichter S. J., Harker L. A. Preparation and storage of platelet concentrates. II. Storage variables influencing platelet viability and function. Br J Haematol. 1976 Nov;34(3):403–419. doi: 10.1111/j.1365-2141.1976.tb03587.x. [DOI] [PubMed] [Google Scholar]
  54. Smith J. B., Ingerman C., Kocsis J. J., Silver M. J. Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction. J Clin Invest. 1974 May;53(5):1468–1472. doi: 10.1172/JCI107695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Steele P. P., Weily H. S., Davies H., Genton E. Platelet function studies in coronary artery disease. Circulation. 1973 Dec;48(6):1194–1200. doi: 10.1161/01.cir.48.6.1194. [DOI] [PubMed] [Google Scholar]
  56. Steele P., Rainwater J., Vogel R., Genton E. Platelet-suppressant therapy in patients with coronary artery disease. JAMA. 1978 Jul 21;240(3):228–231. [PubMed] [Google Scholar]
  57. Steiner M., Anastasi J. Vitamin E. An inhibitor of the platelet release reaction. J Clin Invest. 1976 Mar;57(3):732–737. doi: 10.1172/JCI108331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Svensson J., Hamberg M., Samuelsson B. On the formation and effects of thromboxane A2 in human platelets. Acta Physiol Scand. 1976 Nov;98(3):285–294. doi: 10.1111/j.1748-1716.1976.tb10313.x. [DOI] [PubMed] [Google Scholar]
  59. Wall R. T., Harker L. A., Quadracci L. J., Striker G. E. Factors influencing endothelial cell proliferation in vitro. J Cell Physiol. 1978 Aug;96(2):203–213. doi: 10.1002/jcp.1040960209. [DOI] [PubMed] [Google Scholar]
  60. Weiss H. J., Tschopp T. B., Baumgartner H. R. Impaired interaction (adhesion-aggregation) of platelets with the subendothelium in storage-pool disease and after aspirin ingestion. A comparison with von Willebrand's disease. N Engl J Med. 1975 Sep 25;293(13):619–623. doi: 10.1056/NEJM197509252931301. [DOI] [PubMed] [Google Scholar]
  61. Weiss H. J., Turitto V. T. Prostacyclin (prostaglandin I2, PGI2) inhibits platelet adhesion and thrombus formation on subendothelium. Blood. 1979 Feb;53(2):244–250. [PubMed] [Google Scholar]
  62. Wilkinson A. R., Hawker R. J., Hawker L. M. The influence of antiplatelet drugs on platelet survival after aortic damage or implantation of a dacron arterial prothesis. Thromb Res. 1979;15(1-2):181–189. doi: 10.1016/0049-3848(79)90063-x. [DOI] [PubMed] [Google Scholar]
  63. Wu K. K., Hoak J. C. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet. 1974 Oct 19;2(7886):924–926. doi: 10.1016/s0140-6736(74)91131-3. [DOI] [PubMed] [Google Scholar]
  64. Zwaal R. F. Membrane and lipid involvement in blood coagulation. Biochim Biophys Acta. 1978 Jul 31;515(2):163–205. doi: 10.1016/0304-4157(78)90003-5. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES